First-in-class versus best-in-class: an update for new market dynamics.
Nat Rev Drug Discov
; 22(7): 531-532, 2023 Jul.
Article
in En
| MEDLINE
| ID: mdl-37095355
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Nat Rev Drug Discov
Journal subject:
FARMACOLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2023
Document type:
Article
Country of publication:
Reino Unido